Cancer Screening

American Association for Cancer Research released a first-of-its-kind report detailing the impact of the COVID-19 pandemic on the cancer community, both in patient care and research practice.

The U.S. Preventive Services Task Force’s 2021 guideline for lung cancer screening improved upon previous fixed-screening criteria and may reduce racial disparities in access, according to a study published in JAMA Oncology.

President Joe Biden has unfinished business with cancer.

Women with diabetes were significantly less likely to complete a mammogram than women without the condition, according to an analysis of electronic health records from a single institution.

PSA testing rates increased after the U.S. Preventive Services Task Force revised its guidance on prostate cancer screening in 2017, according to results of a large national cohort study in JAMA Oncology.

The proportion of women in the U.S. who were not up to date on recommended cervical cancer screening significantly increased from 2005 to 2019, according to findings published in JAMA Network Open.

Non-speculum sampling by clinicians and self-sampling “substantially increased” cervical cancer screening uptake in women aged 50 to 64 years who were overdue for screening, according to researchers.

A blood test based on a four-marker protein panel combined with an independent risk prediction model that accounts for smoking history significantly improved patient selection for lung cancer screening, according to study results.

Increased incidence of early-onset colorectal cancer and precancerous polyp diagnoses among patients at a younger age supported the recommendation for CRC screening at age 45 for all average risk individuals, according to a study.

In this video, Anne Marie McCarthy, PhD, ScM, assistant professor of epidemiology at University of Pennsylvania’s Perelman School of Medicine, discusses findings from her research on polygenic risk score.